Drug
Methylergonovine clinical trials
Also written Methergine.
Keep track of what changes. Save the Methylergonovine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 8
Brigham and Women's Hospital (2) · Columbia University (1) · Cynthia Wong (1) · University of California, San Francisco (1) · University of South Florida (1) · Cairo University (1) · Johns Hopkins University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Methylergonovine is read from its arms, and is right about nine times in ten.
Testing it · 8
- Ergometrine Versus Carbetocin to Decrease Blood Loss in MyomectomyRecruitingNot applicableCairo UniversityNCT07390864Written as Methylergometrine (Intramyometrial Injection)
- Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical TrialCompletedPhase 4Brigham and Women's HospitalNCT03584854Written as Methylergonovine Maleate
- Prophylactic Methylergonovine for Twin CesareanCompletedPhase 4Columbia UniversityNCT05772156Written as Methylergonovine
- Multimodal Uterotonics at the Time of Cesarean Section in Laboring PatientsCompletedPhase 4Cynthia WongNCT03904446Written as Methylergonovine
- Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean SectionsWithdrawnEarly Phase 1Johns Hopkins UniversityNCT03303235Written as Methylergonovine
- Uterotonic Prophylaxis TrialCompletedPhase 4University of California, San FranciscoNCT02408965Written as Methergine
- Oxytocin And Uterotonic Agent Use For Cesarean DeliveryCompletedPhase 4Brigham and Women's HospitalNCT01549223Written as Oxytocin Bolus
- Reduction of Endometritis After Cesarean Section With the Routine Use of MethergineCompletedNot applicableUniversity of South FloridaNCT00858832Written as Methergine
Codes
What other systems call Methylergonovine · ClinicalTrials.gg INT007818
- MeSH (NLM) D008755MethylergonovineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) W53L6FE61VMETHYLERGONOVINEConfirmed FDA, NLM, Wikidata
- RxNorm 6883Confirmed FDA, Wikidata
- Wikidata Q424477methylergonovineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74105MethylergonovineOne source FDA
- DrugBank DB00353One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008755 | Methylergonovine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | W53L6FE61V | METHYLERGONOVINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6883 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424477 | methylergonovine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74105 | Methylergonovine | One source FDA |
| DrugBank | DB00353 | — | One source Wikidata |
Also registered as methylergonovine maleate (UNII IR84JPZ1RK · RxNorm 84158).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.